K&L Gates Health Care Triage

K&L Gates Health Care Triage

K&L Gates

Triage: Rapid Legal Lessons for Busy Health Care Professionals has been created by K&L Gates to convey information about developments in health law through short podcasts. If you work in the health care industry, you have grown accustomed to frequent changes in laws and regulations. On some days, it may seem like an insurmountable task to keep up with every change, especially as a new presidential administration and new policies take shape. The K&L Gates Health Care practice will regularly create Triage podcasts to help you learn about the latest developments in health law. Our lawyers will identify the most important changes and analyze the impact of these changes on our clients.

Categorias: Finanzas

Escuchar el último episodio:

In this two-part Triage series, Gina Bertolini, Stephen Page, and Sarah Staples-Carlton discuss an old health care regulatory doctrine that has new relevance in a post-COVID world, where the delivery of care via telemedicine and other remote models has become heavily adopted: Corporate Practice of Medicine, or “CPOM.” As more and more health care companies look for innovative ways to deliver healthcare, it can be easy for seasoned healthcare professionals and newcomers alike to discount or dismiss CPOM. While on its face it is a straightforward prohibition, it is important to understand the doctrine’s underlying philosophy and to appreciate its complexity, particularly how it varies from state to state. This is particularly the case where telehealth has become an established method for the delivery of care, and many new companies are entering the health care space. As health care entities, health IT solutions providers, and other companies seek to deliver care in one or more states, there are many health care regulatory considerations to consider, but CPOM should be at the top of the list. 

In part one of this series, Gina Bertolini, Stephen Page, and Sarah Staples-Carlton offer a brief primer on CPOM, answer some practical questions about its impact, and elaborate on its present-day relevance for health care providers and other companies.

Episodios anteriores

  • 181 - Corporate Practice of Medicine: New Relevance in a Changing World 
    Tue, 09 Apr 2024 - 0h
  • 180 - Health System Cybersecurity Risks: Part Two 
    Mon, 01 Apr 2024 - 0h
  • 179 - Health System Cybersecurity Risks: Part One 
    Tue, 26 Mar 2024 - 0h
  • 178 - Highlights from FDA Regulatory Developments in Clinical Trials: 2023 Recap and 2024 Forecast 
    Tue, 05 Mar 2024 - 0h
  • 177 - FDA Issues Guidance on Informed Consent for IRBs, Clinical Investigators, and Sponsors 
    Thu, 12 Oct 2023 - 0h
Mostrar más episodios

Más podcasts finanzas de El Salvador

Más podcasts finanzas internacionales

Elige la categoria de podcast